Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kewaunee Scientific (KEQU) Cost of Revenue (2016 - 2026)

Kewaunee Scientific (KEQU) has 16 years of Cost of Revenue data on record, last reported at $50.4 million in Q4 2025.

  • For Q4 2025, Cost of Revenue rose 48.99% year-over-year to $50.4 million; the TTM value through Oct 2025 reached $202.4 million, up 38.16%, while the annual FY2025 figure was $171.6 million, 13.12% up from the prior year.
  • Cost of Revenue reached $50.4 million in Q4 2025 per KEQU's latest filing, roughly flat from $50.2 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $53.1 million in Q2 2025 and bottomed at $27.7 million in Q1 2021.
  • Average Cost of Revenue over 5 years is $40.6 million, with a median of $39.2 million recorded in 2022.
  • Peak YoY movement for Cost of Revenue: tumbled 31.18% in 2024, then skyrocketed 48.99% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $35.4 million in 2021, then increased by 29.43% to $45.9 million in 2022, then dropped by 19.39% to $37.0 million in 2023, then decreased by 8.54% to $33.8 million in 2024, then surged by 48.99% to $50.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $50.4 million in Q4 2025, $50.2 million in Q3 2025, and $53.1 million in Q2 2025.